Help With Estrogen Patch Shortages
May 2026
High demand and shortages are leading to questions about estrogen patches for menopausal hormone therapy (MHT).
More patients are opting to use MHT after FDA’s decision to remove certain boxed warnings. Plus transdermal meds are often preferred over oral options...since they’re associated with a lower risk of blood clots.
Keep in mind, most evidence for transdermal estrogen is with patches and based on observational studies. All forms of systemic estrogen seem similar in efficacy at reducing vasomotor symptoms.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote